http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2412535-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_430173a8ec6592d6fd4d799c44a42751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25412c2cc8cc758f2666c5c7b10c182a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c889f968aaef65b23c2f09ddeb3ec94c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e6c03f397355d2b99dd3003fccfdd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167dc591c30d253ffe2c979b68ef9465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519b568120c950faf3180b9f7f187a5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6132956488a00b42b77bbf927936c39
publicationDate 2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2412535-A1
titleOfInvention Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride
abstract There are described polymorphic forms/hydrates of N-[4-(3-chloro-4- fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action.
priorityDate 2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450165613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 40.